Listeria brain abscess, Pneumocystis pneumonia and Kaposi's sarcoma after temozolomide

Nat Clin Pract Oncol. 2006 Jun;3(6):339-43; quiz following 343. doi: 10.1038/ncponc0514.

Abstract

Background: A 55-year-old man with glioblastoma multiforme was treated with continuous, dose-dense temozolomide. This therapy was curtailed after three cycles because of nausea, asthenia, and neuropsychological deterioration. During a subsequent course of radiotherapy, the patient developed fever, headaches, and cutaneous lesions.

Investigations: Physical examination, cerebral MRI, brain biopsy, skin biopsy, immunohistochemistry, bronchoscopy with bronchoalveolar lavage, and laboratory tests.

Diagnosis: Severe temozolomide-induced immunosuppression, exacerbated by corticosteroids, with profound T-cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.

Management: Discontinuation of temozolomide, discontinuation of radiotherapy, antibiotic treatment with amoxicillin and gentamicin, and administration of atovaquone and pentamidine.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents, Alkylating / adverse effects*
  • Brain Abscess / chemically induced*
  • Brain Abscess / drug therapy
  • Brain Abscess / pathology
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / surgery
  • Dacarbazine / adverse effects
  • Dacarbazine / analogs & derivatives*
  • Glioblastoma / drug therapy*
  • Glioblastoma / surgery
  • Humans
  • Listeriosis / chemically induced*
  • Listeriosis / drug therapy
  • Listeriosis / pathology
  • Male
  • Middle Aged
  • Neoadjuvant Therapy / adverse effects
  • Pneumocystis carinii*
  • Pneumonia, Pneumocystis / chemically induced*
  • Pneumonia, Pneumocystis / drug therapy
  • Sarcoma, Kaposi / chemically induced*
  • Sarcoma, Kaposi / drug therapy
  • Sarcoma, Kaposi / pathology
  • Temozolomide

Substances

  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Temozolomide